Navigation Links
VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
Date:8/19/2008

Private Access Appoints Marc Kirshbaum as President & COO Former Experian Executive Will Lead Private Access' Mission to Accelerate Medical Research through its suite of web-based privacy management and

clinical trials recruitment tools

ALISO VIEJO, Calif., Aug. 19 /PRNewswire-FirstCall/ -- Private Access, Inc., a developer of web-based solutions that enable management of detailed privacy preferences for personal health information, announced today that the former President of Experian plc's Business Information Services Group and Fraud and Identity Solutions business, Marc D. Kirshbaum, has been hired as President and COO. Capitalizing on its expertise in technology, information management and healthcare, the company is developing software solutions to help overcome the impediments that slow the medical community's ability to more quickly find causes for chronic illnesses and diseases.

"Launching our solutions will create a trusted environment for individuals to balance their desire for privacy with respect to their health information with the desire to share information when sharing information can improve their medical care and the care of others," said Kirshbaum. "Creating solutions that will overcome obstacles that currently slow the medical community's ability to more quickly and more cost-effectively find causes and treatments for chronic illnesses and diseases is all the inspiration I needed to join Private Access and ensure its success. I am honored to have the opportunity to lead Private Access," he added. "Over the next six months we are laser-focused on product development, aligning with strategic partners and securing additional capital for the company."

During his six-year tenure with Experian, Kirshbaum led the transformation and acceleration of multiple businesses and revamped operations, focusing on improving the client experience. Under his leadership, strong teams were built that brought increased focus to the key drivers of success for clients, employees and the business, resulting in consistent revenue growth and increased profitability in highly competitive markets. Prior to joining Experian, Kirshbaum held strategic and operational roles with technology and information companies. Kirshbaum also was a lawyer in private practice.

"We are very pleased to be completing our initial research and development period and entering the next stage of our growth, where we will go to market with the first technologically seamless application that harmonizes privacy and access," said Robert H. Shelton, the company's co-Founder, Chairman and Chief Executive Officer. "Marc's breadth and depth of experience in strategy and operations within technology and information companies will assure a successful launch and accelerate our growth. With his guidance, we are pursuing our next round of funding from a combination of non-profit, strategic and private sources. We are fortunate to have such a dynamic and experienced leader on board at this critical time."

Shelton will remain essential to the company's success, focusing much of his energy on the company's novel public/private partnerships and its product vision. "Private Access is clearly ready to enter a new chapter, which comes at a time when the broader market is demanding privacy solutions," said Shelton, who will announce the company's plans today during a plenary session at the prestigious Harvard Privacy Symposium. "The opportunity to introduce the company at the Harvard conference, coupled with the addition of an accomplished President in Marc, will position Private Access as an industry pioneer poised to address the critical obstacle facing medical researchers and disease advocacy organizations in order to significantly accelerate their ability to find causes and treatments for diseases and chronic illnesses."

About Private Access

Private Access, Inc. develops web-based applications that solve the significant privacy hurdle that the medical community faces when attempting to recruit subjects for clinical trials and to share confidential records in pursuit of faster diagnoses and better treatments for diseases and chronic illnesses. The company's vision is to leverage its method for individuals to establish and manage their dynamic electronic consent and its suite of solutions to transform the healthcare industry - creating a unique environment of trust for consumers and accelerating research at a considerably lower cost. Founded in 2006, Private Access is headquartered in Aliso Viejo, California and holds several patents covering its proprietary technology. For more information, visit http://www.PrivateAccess.info .

Contact: Geri L. Schanz, APR, 949-499-1869

or Contact: Shareholder Relations

VirtualHealth Technologies, Inc.

325 West Main Street, Suite 240

Lexington, KY 40507

(859) 455-9255

Email: Shareholder.Relations@virtualhealthtechnologies.com

Website: http://www.virtualhealthtechnologies.com


'/>"/>
SOURCE VirtualHealth Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. VirtualHealth Technologies, Inc. Announces Management Appointment
2. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
3. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
4. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
5. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
6. ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
7. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
8. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
9. ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
10. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
11. ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: